Advancing Regulatory Oversight of Medical Device Trials to Align with Clinical Drug Standards in the European Union
The regulation of clinical trials for medicinal products and medical devices has undergone numerous changes in recent years in the European Union, challenging manufacturers and national regulatory agencies as well. With the introduction of combined drug–device products, the regulatory landscape has...
Saved in:
| Main Authors: | Ádám Pannonhalmi, Bence Sipos, Róbert Imre Kurucz, Gábor Katona, Lajos Kemény, Ildikó Csóka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/6/876 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory landscape of accelerated approval pathways for medical devices in the United States and the European Union
by: Tanvi Gupte, et al.
Published: (2025-05-01) -
A normalized quality of life approach for regulatory approval of medical devices
by: Leuchter Matthias, et al.
Published: (2024-12-01) -
Cybersecurity requirements for medical devices in the EU and US - A comparison and gap analysis of the MDCG 2019–16 and FDA premarket cybersecurity guidance
by: Max Ostermann, et al.
Published: (2025-01-01) -
Advances in medical devices using nanomaterials and nanotechnology: Innovation and regulatory science
by: Chubing Lin, et al.
Published: (2025-06-01) -
Global Regulatory Challenges for Medical Devices: Impact on Innovation and Market Access
by: Carolina Amaral, et al.
Published: (2024-10-01)